Search

everythinglearnresearchcommunity

for

Search:↓

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Women with congenital adrenal hyperplasia showed no prostatic growth.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Men with enlarged prostates often have more severe baldness.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride does not prevent bladder cancer.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.